Host bone marrow-derived IL-12 enhances donor T cell engraftment in a mouse model of bone marrow transplantation

Journal of Hematology and Oncology

Volumn 7, Issue 1, 2014, Pages

  Darlak, Katarzyna A ^a   Wang, Ying ^a,b   Li, Jian Ming ^a   Harris, Wayne A C ^a   Giver, Cynthia R ^a   Huang, Chunzi ^a   Waller, Edmund K ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Engraftment; Interleukin 12; T cells; Transplantation

Indexed keywords

CD45 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P40; THY 1 ANTIGEN; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW TRANSPLANTATION; CD4+ T LYMPHOCYTE; CELL EXPANSION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DONOR; ENGRAFTMENT; ERYTHROCYTE; GRAFT FAILURE; HEMATOPOIETIC CELL; LEUKOCYTE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; RADIATION CHIMERA; T LYMPHOCYTE; THROMBOCYTE; ANIMAL; C57BL MOUSE; DISEASE MODEL; IMMUNOLOGY; PROCEDURES; TRANSPLANTATION;

ANIMALS; BONE MARROW TRANSPLANTATION; DISEASE MODELS, ANIMAL; INTERLEUKIN-12; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES; TISSUE DONORS;

EID: 84899478105     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-7-16     Document Type: Article

References (39)

1. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Rocha V, Cornish J, Sievers EL, Filipovich A, Locatelli F, Peters C, Remberger M, Michel G, Arcese W, Dallorso S, Tiedemann K, Busca A, Chan KW, Kato S, Ortega J, Vowels M, Zander A, Souillet G, Oakill A, Woolfrey A, Pay AL, Green A, Garnier F, Ionescu I, Wernet P, Sirchia G, Rubinstein P, Chevret S, Gluckman E, Blood 2001 97 2962 2971 10.1182/blood.V97.10.2962 11342418
2. Peripheral-blood stem cells versus bone marrow from unrelated donors. Anasetti C, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, Wingard JR, Cutler CS, Westervelt P, Woolfrey A, Couban S, Ehninger G, Johnston L, Maziarz RT, Pulsipher MA, Porter DL, Mineishi S, McCarty JM, Khan SP, Anderlini P, Bensinger WI, Leitman SF, Rowley SD, Bredeson C, Carter SL, Horowitz MM, Confer DL, N Engl J Med 2012 367 1487 1496 10.1056/NEJMoa1203517 23075175
3. A comparison of nonmyeloablative and reduced-intensity conditioning for allogeneic stem-cell transplantation. Le Blanc K, Remberger M, Uzunel M, Mattsson J, Barkholt L, Ringden O, Transplantation 2004 78 1014 1020 10.1097/01.TP.0000129809.09718.7E 15480167
4. Marrow grafts by combined marrow and leukocyte infusions in unrelated dogs selected by histocompatibility typing. Storb R, Epstein RB, Bryant J, Ragde H, Thomas ED, Transplantation 1968 6 587 593 10.1097/00007890-196807000-00011 4876499
5. Abrogation of resistance to and enhancement of DLA-nonidentical unrelated marrow grafts in lethally irradiated dogs by thoracic duct lymphocytes. Deeg HJ, Storb R, Weiden PL, Shulman HM, Graham TC, Torok-Storb BJ, Thomas ED, Blood 1979 53 552 557 371633
6. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Shlomchik WD, Couzens MS, Tang CB, McNiff J, Robert ME, Liu J, Shlomchik MJ, Emerson SG, Science 1999 285 412 415 10.1126/science.285.5426.412 10411505
7. Enrichment of IL-12-producing plasmacytoid dendritic cells in donor bone marrow grafts enhances graft-versus-leukemia activity in allogeneic hematopoietic stem cell transplantation. Darlak KA, Wang Y, Li JM, Harris WA, Owens LM, Waller EK, Biol Blood Marrow Transplant 2013 19 9 1331 9 10.1016/j.bbmt.2013.06.016 23810844
8. Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice. Yang YG, Sergio JJ, Pearson DA, Szot GL, Shimizu A, Sykes M, Blood 1997 90 4651 4660 9373279
9. IL-12 protects bone marrow from and sensitizes intestinal tract to ionizing radiation. Neta R, Stiefel SM, Finkelman F, Herrmann S, Ali N, J Immunol 1994 153 4230 4237 7930625
10. IL-12 facilitates both the recovery of endogenous hematopoiesis and the engraftment of stem cells after ionizing radiation. Chen T, Burke KA, Zhan Y, Wang X, Shibata D, Zhao Y, Exp Hematol 2007 35 203 213 10.1016/j.exphem.2006.10. 002 17258069
11. IL-12 is expressed and released by human keratinocytes and epidermoid carcinoma cell lines. Aragane Y, Riemann H, Bhardwaj RS, Schwarz A, Sawada Y, Yamada H, Luger TA, Kubin M, Trinchieri G, Schwarz T, J Immunol 1994 153 5366 5372 7527439
12. Staphylococcus aureus infection of mouse or human osteoblasts induces high levels of interleukin-6 and interleukin-12 production. Bost KL, Ramp WK, Nicholson NC, Bento JL, Marriott I, Hudson MC, J Infect Dis 1999 180 1912 1920 10.1086/315138 10558948
13. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Cooke KR, Kobzik L, Martin TR, Brewer J, Delmonte J Jr, Crawford JM, Ferrara JL, Blood 1996 88 3230 3239 8963063
14. Mechanisms of antigen presentation to T cells in murine graft-versus-host disease: cross-presentation and the appearance of cross-presentation. Wang X, Li H, Matte-Martone C, Cui W, Li N, Tan HS, Roopenian D, Shlomchik WD, Blood 2011 118 6426 6437 10.1182/blood-2011-06-358747 21963602
15. Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway. Haspot F, Fehr T, Gibbons C, Zhao G, Hogan T, Honjo T, Freeman GJ, Sykes M, Blood 2008 112 2149 2155 10.1182/blood-2007-12-127449 18577709
16. Interleukin-12 inhibits murine graft-versus-host disease. Sykes M, Szot GL, Nguyen PL, Pearson DA, Blood 1995 86 2429 2438 7662991
17. Interleukin-12 prevents severe acute graft-versus-host disease (GVHD) and GVHD-associated immune dysfunction in a fully major histocompatibility complex haplotype-mismatched murine bone marrow transplantation model. Yang YG, Dey B, Sergio JJ, Sykes M, Transplantation 1997 64 1343 1352 10.1097/00007890- 199711150-00018 9371678
18. Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12. Yang YG, Dey BR, Sergio JJ, Pearson DA, Sykes M, J Clin Invest 1998 102 2126 2135 10.1172/JCI4992 9854048
19. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Mullen AC, High FA, Hutchins AS, Lee HW, Villarino AV, Livingston DM, Kung AL, Cereb N, Yao TP, Yang SY, Reiner SL, Science 2001 292 1907 1910 10.1126/science.1059835 11397944
20. T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells. Afkarian M, Sedy JR, Yang J, Jacobson NG, Cereb N, Yang SY, Murphy TL, Murphy KM, Nat Immunol 2002 3 549 557 12006974
21. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Hutloff A, Dittrich AM, Beier KC, Eljaschewitsch B, Kraft R, Anagnostopoulos I, Kroczek RA, Nature 1999 397 263 266 10.1038/16717 9930702
22. Cutting edge: the related molecules CD28 and inducible costimulator deliver both unique and complementary signals required for optimal T cell activation. Gonzalo JA, Delaney T, Corcoran J, Goodearl A, Gutierrez-Ramos JC, Coyle AJ, J Immunol 2001 166 1 5 11123268
23. B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha. Swallow MM, Wallin JJ, Sha WC, Immunity 1999 11 423 432 10.1016/S1074-7613(00)80117-X 10549624
24. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Agata Y, Kawasaki A, Nishimura H, Ishida Y, Tsubata T, Yagita H, Honjo T, Int Immunol 1996 8 765 772 10.1093/intimm/8.5.765 8671665
25. Activation-induced expression of human programmed death-1 gene in T-lymphocytes. Vibhakar R, Juan G, Traganos F, Darzynkiewicz Z, Finger LR, Exp Cell Res 1997 232 25 28 10.1006/excr.1997.3493 9141617
26. Expression of programmed death 1 ligands by murine T cells and APC. Yamazaki T, Akiba H, Iwai H, Matsuda H, Aoki M, Tanno Y, Shin T, Tsuchiya H, Pardoll DM, Okumura K, Azuma M, Yagita H, J Immunol 2002 169 5538 5545 12421930
27. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Dong H, Zhu G, Tamada K, Chen L, Nat Med 1999 5 1365 1369 10.1038/70932 10581077
28. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H, Fitz LJ, Malenkovich N, Okazaki T, Byrne MC, Horton HF, Fouser L, Carter L, Ling V, Bowman MR, Carreno BM, Collins M, Wood CR, Honjo T, J Exp Med 2000 192 1027 1034 10.1084/jem.192.7.1027 11015443
29. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Latchman Y, Wood CR, Chernova T, Chaudhary D, Borde M, Chernova I, Iwai Y, Long AJ, Brown JA, Nunes R, Greenfield EA, Bourque K, Boussiotis VA, Carter LL, Carreno BM, Malenkovich N, Nishimura H, Okazaki T, Honjo T, Sharpe AH, Freeman GJ, Nat Immunol 2001 2 261 268 10.1038/85330 11224527
30. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. Tseng SY, Otsuji M, Gorski K, Huang X, Slansky JE, Pai SI, Shalabi A, Shin T, Pardoll DM, Tsuchiya H, J Exp Med 2001 193 839 846 10.1084/jem.193.7.839 11283156
31. PD-1 and its ligands in T-cell immunity. Keir ME, Francisco LM, Sharpe AH, Curr Opin Immunol 2007 19 309 314 10.1016/j.coi.2007.04.012 17433872
32. Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal. Fife BT, Pauken KE, Eagar TN, Obu T, Wu J, Tang Q, Azuma M, Krummel MF, Bluestone JA, Nat Immunol 2009 10 1185 1192 10.1038/ni.1790 19783989
33. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, Vega F, Yu N, Wang J, Singh K, Zonin F, Vaisberg E, Churakova T, Liu M, Gorman D, Wagner J, Zurawski S, Liu Y, Abrams JS, Moore KW, Rennick D, de Waal-Malefyt R, Hannum C, Bazan JF, Kastelein RA, Immunity 2000 13 715 725 10.1016/S1074-7613(00)00070-4 11114383
34. Th17: the third member of the effector T cell trilogy. Bettelli E, Korn T, Kuchroo VK, Curr Opin Immunol 2007 19 652 657 10.1016/j.coi.2007.07.020 17766098
35. Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease. Hanash AM, Dudakov JA, Hua G, O'Connor MH, Young LF, Singer NV, West ML, Jenq RR, Holland AM, Kappel LW, Ghosh A, Tsai JJ, Rao UK, Yim NL, Smith OM, Velardi E, Hawryluk EB, Murphy GF, Liu C, Fouser LA, Kolesnick R, Blazar BR, van den Brink MR, Immunity 2012 37 339 350 10.1016/j.immuni.2012.05.028 22921121
36. Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease. Yi T, Zhao D, Lin CL, Zhang C, Chen Y, Todorov I, LeBon T, Kandeel F, Forman S, Zeng D, Blood 2008 112 2101 2110 10.1182/blood-2007-12-126987 18596226
37. Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease. Yi T, Chen Y, Wang L, Du G, Huang D, Zhao D, Johnston H, Young J, Todorov I, Umetsu DT, Chen L, Iwakura Y, Kandeel F, Forman S, Zeng D, Blood 2009 114 3101 3112 10.1182/blood-2009-05-219402 19602708
38. In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity. Nishimura R, Baker J, Beilhack A, Zeiser R, Olson JA, Sega EI, Karimi M, Negrin RS, Blood 2008 112 2563 2574 10.1182/blood-2007-06-092817 18565854
39. Irradiated donor leukocytes promote engraftment of allogeneic bone marrow in major histocompatibility complex mismatched recipients without causing graft-versus-host disease. Waller EK, Ship AM, Mittelstaedt S, Murray TW, Carter R, Kakhniashvili I, Lonial S, Holden JT, Boyer MW, Blood 1999 94 3222 3233 10556211